Picture of Tactile Systems Technology logo

TCMD Tactile Systems Technology Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Momentum

Relative Strength (%)
1m-15.17%
3m-33.96%
6m-30.77%
1yr-62.98%
Volume Change (%)
10d/3m+6.27%
Price vs... (%)
52w High-56.45%
50d MA-14.76%
200d MA-18.31%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.77
PEG Ratio (f)n/a
EPS Growth (f)-21.4%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.4
Price to Tang. Book2.32
Price to Free Cashflow7.81
Price to Sales0.98
EV to EBITDA8.79

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.9%
Return on Equity16.13%
Operating Margin6.83%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m189.49187.13208.06246.78274.42302.95341.1513.81%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+63.17-91.3n/an/an/a-53.43+54.1n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Tactile Systems Technology EPS forecast chart

Profile Summary

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
July 21st, 2006
Public Since
July 28th, 2016
No. of Shareholders
26
No. of Employees
992
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
23,762,164

TCMD Share Price Performance

Upcoming Events for TCMD

Q2 2024 Tactile Systems Technology Inc Earnings Release

Q3 2024 Tactile Systems Technology Inc Earnings Release

Similar to TCMD

Picture of 908 Devices. logo

908 Devices.

us flag iconNASDAQ Global Market

Picture of Alpha Teknova logo

Alpha Teknova

us flag iconNASDAQ Global Market

Picture of AtriCure logo

AtriCure

us flag iconNASDAQ Global Market

Picture of Brainsway logo

Brainsway

us flag iconNASDAQ Global Market

Picture of Castle Biosciences logo

Castle Biosciences

us flag iconNASDAQ Global Market

FAQ